Skip to content

Clinical trials

Terminated Neoplasm Metastasis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Terminated Country / region: Australia Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20091
20101
20122
20133
20141
20153
20162
20172
20182
20195
20205
20218
20224
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Clovis Oncology, Inc.3
BeiGene2
Eli Lilly and Company2
Hoffmann-La Roche2
Odonate Therapeutics, Inc.2
Pfizer2
Takeda2
AbbVie1
Alaunos Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis44
Carcinoma, Non-Small-Cell Lung14
Neoplasms10
Colorectal Neoplasms7
Recurrence6
Lung Neoplasms5
Melanoma5
Breast Neoplasms4
Cholangiocarcinoma3
Sarcoma3

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.